Emerge Diagnostics

Emerge Diagnostics is a United States-based company located in Carlsbad, California. The company employs 26 individuals and generates approximately $7 million in annual revenue. Emerge Diagnostics specializes in developing diagnostic tools for musculoskeletal injuries. Their flagship product, the Electrodiagnostic Functional Assessment (EFA), is an FDA-registered, class-II diagnostic device. This device allows for the assessment of muscle activity, differentiation between acute and chronic injuries, and objective quantification of effort. Emerge Diagnostics also offers the EFA-Soft Tissue Management (STM) Program, a patent-pending process designed for employers. This program utilizes baseline assessments, stored securely, to compare with post-injury assessments, providing objective data for accurate diagnosis and treatment of soft-tissue injuries. Interested parties can connect with Emerge Diagnostics through their website, emergedx.com, or by signing up for their mailing list at http://eepurl.com/bCKCk5.